SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-3.48 Cr | ₹27 Cr | ₹41 Cr | ₹55 Cr | ₹32 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-3.48 Cr |
| Mar2024 | ₹27 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹55 Cr |
| Mar2021 | ₹32 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.48 Cr | Negative | |
| Mar2024 | ₹27 Cr | -33.22 | |
| Mar2023 | ₹41 Cr | -24.76 | |
| Mar2022 | ₹55 Cr | 70.51 | |
| Mar2021 | ₹32 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,250.9 Cr | 17.4% | 10.2% | 202.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 17.4% |
10.2% |
202.9% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses